Genezen – UF Innovate https://innovate.research.ufl.edu Building business on innovation Tue, 20 Jan 2026 16:18:22 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png Genezen – UF Innovate https://innovate.research.ufl.edu 32 32 Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership (PR Newswire) https://innovate.research.ufl.edu/genezen-and-atsena-therapeutics-manufacturing-partnership/ Tue, 20 Jan 2026 16:18:22 +0000 https://innovate.research.ufl.edu/?p=21184 Genezen, a leading gene therapy contract development and manufacturing organization (CDMO), and UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, announced a strategic manufacturing partnership to advance the clinical development and commercial manufacturing of Atsena’s pipeline programs powered by novel adeno-associated virus (AAV) technology engineered to overcome the hurdles presented by inherited retinal diseases. Atsena’s lead program is evaluating ATSN-201 in the pivotal LIGHTHOUSE study for the treatment of X-linked retinoschisis (XLRS) and is on track for a potential Biologics License Application filing in early 2028.

 

Read more about Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership.

]]>